UPDATE: Morgan Stanley Removes PT on Express Scripts on Management Meeting Takeaways

In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Express Scripts Holding Company (NASDAQ: ESRX ), but removed the $70.00 price target. In the report, Morgan Stanley noted, “2013/2014 selling season in line with expectations, with EBIT retention ahead of revenue retention rate.